Cubist Systematic Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17M | Buy |
+377,758
| New | +$17.6M | 0.08% | 329 |
|
|
2025
Q1 | – | Sell |
-47,100
| Closed | -$2.75M | – | 2889 |
|
|
2024
Q4 | $2.66M | Buy |
47,100
+41,060
| +680% | +$2.29M | 0.02% | 1187 |
|
|
2024
Q3 | $312K | Sell |
6,040
-881,127
| -99% | -$41.3M | ﹤0.01% | 2411 |
|
|
2024
Q2 | $36.8M | Buy |
+887,167
| New | +$39.7M | 0.25% | 47 |
|
|
2024
Q1 | – | Sell |
-753,391
| Closed | -$38.4M | – | 3738 |
|
|
2023
Q4 | $38.7M | Buy |
753,391
+749,012
| +17,105% | +$39.3M | 0.25% | 25 |
|
|
2023
Q3 | $254K | Sell |
4,379
-788,858
| -99% | -$48.3M | ﹤0.01% | 2669 |
|
|
2023
Q2 | $50.7M | Buy |
793,237
+694,069
| +700% | +$46.5M | 0.34% | 16 |
|
|
2023
Q1 | $6.87M | Sell |
99,168
-329,308
| -77% | -$23.2M | 0.04% | 698 |
|
|
2022
Q4 | $30.8M | Buy |
+428,476
| New | +$32.3M | 0.18% | 45 |
|
|
2022
Q3 | – | Sell |
-333,255
| Closed | -$24.2M | – | 4429 |
|
|
2022
Q2 | $25.7M | Buy |
333,255
+170,177
| +104% | +$13M | 0.16% | 71 |
|
|
2022
Q1 | $11.9M | Sell |
163,078
-82,000
| -33% | -$5.51M | 0.1% | 220 |
|
|
2021
Q4 | $15.3M | Buy |
245,078
+47,566
| +24% | +$2.79M | 0.15% | 94 |
|
|
2021
Q3 | $11.7M | Buy |
197,512
+134,815
| +215% | +$8.88M | 0.15% | 147 |
|
|
2021
Q2 | $4.19M | Sell |
62,697
-221,342
| -78% | -$14.4M | 0.05% | 638 |
|
|
2021
Q1 | $17.9M | Buy |
284,039
+127,863
| +82% | +$7.96M | 0.23% | 43 |
|
|
2020
Q4 | $9.69M | Sell |
156,176
-27,065
| -15% | -$1.66M | 0.13% | 167 |
|
|
2020
Q3 | $11M | Sell |
183,241
-20,125
| -10% | -$1.21M | 0.16% | 111 |
|
|
2020
Q2 | $12M | Buy |
203,366
+146,941
| +260% | +$8.79M | 0.21% | 83 |
|
|
2020
Q1 | $3.15M | Sell |
56,425
-26,325
| -32% | -$1.61M | 0.09% | 300 |
|
|
2019
Q4 | $5.31M | Sell |
82,750
-32,157
| -28% | -$1.84M | 0.1% | 279 |
|
|
2019
Q3 | $5.83M | Sell |
114,907
-233,375
| -67% | -$11M | 0.12% | 235 |
|
|
2019
Q2 | $15.8M | Buy |
348,282
+36,819
| +12% | +$1.72M | 0.29% | 49 |
|
|
2019
Q1 | $14.9M | Buy |
311,463
+300,150
| +2,653% | +$15M | 0.48% | 7 |
|
|
2018
Q4 | $588K | Sell |
11,313
-7,458
| -40% | -$401K | 0.03% | 857 |
|
|
2018
Q3 | $1.17M | Sell |
18,771
-11,606
| -38% | -$689K | 0.06% | 405 |
|
|
2018
Q2 | $1.68M | Sell |
30,377
-16,275
| -35% | -$879K | 0.08% | 295 |
|
|
2018
Q1 | $2.95M | Sell |
46,652
-21,753
| -32% | -$1.4M | 0.17% | 132 |
|
|
2017
Q4 | $4.19M | Buy |
68,405
+59,858
| +700% | +$3.74M | 0.22% | 62 |
|
|
2017
Q3 | $545K | Sell |
8,547
-48,010
| -85% | -$2.8M | 0.03% | 767 |
|
|
2017
Q2 | $3.15M | Sell |
56,557
-20,185
| -26% | -$1.1M | 0.2% | 92 |
|
|
2017
Q1 | $4.17M | Buy |
76,742
+23,159
| +43% | +$1.27M | 0.3% | 37 |
|
|
2016
Q4 | $3.13M | Buy |
53,583
+16,416
| +44% | +$897K | 0.25% | 64 |
|
|
2016
Q3 | $2M | Buy |
37,167
+2,867
| +8% | +$184K | 0.13% | 199 |
|
|
2016
Q2 | $2.52M | Buy |
34,300
+32,099
| +1,458% | +$2.27M | 0.15% | 142 |
|
|
2016
Q1 | $141K | Sell |
2,201
-20,697
| -90% | -$1.31M | 0.01% | 1332 |
|
|
2015
Q4 | $1.57M | Sell |
22,898
-34,518
| -60% | -$2.28M | 0.09% | 289 |
|
|
2015
Q3 | $3.4M | Buy |
57,416
+57,407
| +637,856% | +$3.64M | 0.17% | 93 |
|
|
2015
Q2 | $1K | Sell |
9
-127,950
| -100% | -$8.43M | ﹤0.01% | 1792 |
|
|
2015
Q1 | $8.25M | Buy |
127,959
+113,617
| +792% | +$7.11M | 0.4% | 20 |
|
|
2014
Q4 | $847K | Buy |
14,342
+4,504
| +46% | +$254K | 0.05% | 582 |
|
|
2014
Q3 | $504K | Sell |
9,838
-51,910
| -84% | -$2.59M | 0.03% | 813 |
|
|
2014
Q2 | $3M | Buy |
+61,748
| New | +$3.04M | 0.18% | 132 |
|
Other funds holding BMY
Cubist Systematic Strategies's BMY Position: Q3 2025 in Review
Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 377,758 shares worth $17M. The stake represents 0.08% of the portfolio and ranks #329 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in BMY as recently as Q4 2024.
Cubist Systematic Strategies first reported a position in BMY in Q2 2014 and has held it in 42 quarters since. The position peaked at $50.7M in Q2 2023. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Cubist Systematic Strategies held 377,758 shares of Bristol-Myers Squibb worth $17M as of Q3 2025.
- Bristol-Myers Squibb was a new Cubist Systematic Strategies position in Q3 2025.
- Bristol-Myers Squibb made up 0.08% of Cubist Systematic Strategies's portfolio in Q3 2025, its #329 holding.
- Cubist Systematic Strategies first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 42 quarters since.
- Cubist Systematic Strategies's Bristol-Myers Squibb position peaked at $50.7M in Q2 2023.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.